As part of the securPharm initiative ACS PharmaProtect is extending their contract with Arvato Systems for more than another ten years. From February 2019 Arvato Systems will provide further development and operations of their proven IT solutions to combat counterfeit medication.
In accordance with the delegated regulation on EU Counterfeit Directive, from February 9, 2019 onwards all prescription medication will have to have two defined security features: the unique identifier, an individual randomly-generated identification number, which in conjunction with a product code will ensures that every package is unique, and an anti-tampering device that also protects against manipulation. The directive aims to protect patients against the dangers posed by counterfeit medication in the legal supply chain.
As long ago as 2013, as part of a securPharm pilot project, Arvato Systems had already provided an IT system to verify the authenticity of medications throughout the supply chain. To use the end-to-end system the pharmaceutical manufacturer creates a unique identifier during the production process for each pack. At the end of the supply chain, the pharmacist is able to verify and to book out the product when selling it to the patient. The securPharm implementation and the new security features together make this the largest infrastructure project in EU Pharmaceutical supply.